SIG
TMO icon

Stonegate Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Stonegate Investment Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.17M Sell
2,416
-83
-3% -$38.6K 0.03% 171
2025
Q2 		$1.01M Sell
2,499
-4,732
-65% -$1.98M 0.03% 178
2025
Q1 		$3.6M Buy
7,231
+443
+7% +$240K 0.1% 82
2024
Q4 		$3.53M Buy
6,788
+18
+0.3% +$9.9K 0.09% 85
2024
Q3 		$4.19M Buy
6,770
+1,838
+37% +$1.09M 0.11% 80
2024
Q2 		$2.73M Buy
4,932
+130
+3% +$74.5K 0.08% 94
2024
Q1 		$2.79M Buy
4,802
+365
+8% +$205K 0.09% 97
2023
Q4 		$2.36M Buy
4,437
+130
+3% +$62.9K 0.08% 103
2023
Q3 		$2.18M Buy
4,307
+13
+0.3% +$6.93K 0.08% 97
2023
Q2 		$2.24M Buy
4,294
+84
+2% +$45.3K 0.08% 107
2023
Q1 		$2.43M Buy
4,210
+598
+17% +$337K 0.09% 99
2022
Q4 		$1.99M Sell
3,612
-116
-3% -$61.5K 0.09% 98
2022
Q3 		$1.89M Buy
3,728
+31
+0.8% +$17.3K 0.09% 105
2022
Q2 		$2.01M Buy
3,697
+278
+8% +$153K 0.09% 109
2022
Q1 		$2.02M Sell
3,419
-134
-4% -$77K 0.07% 97
2021
Q4 		$2.37M Buy
+3,553
New +$2.22M 0.1% 95

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Stonegate Investment Group's TMO Position: Q3 2025 in Review

Stonegate Investment Group reduced its Thermo Fisher Scientific (TMO) stake by 3.3% in Q3 2025, selling an estimated $38.6K and leaving 2,416 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #171.

Stonegate Investment Group first reported a position in TMO in Q4 2021 and has held it in 16 quarters since. The position peaked at $4.19M in Q3 2024. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

  • Stonegate Investment Group held 2,416 shares of Thermo Fisher Scientific worth $1.17M as of Q3 2025.
  • Stonegate Investment Group sold 83 Thermo Fisher Scientific shares in Q3 2025, an estimated $38.6K.
  • Thermo Fisher Scientific made up 0.03% of Stonegate Investment Group's portfolio in Q3 2025, its #171 holding.
  • Stonegate Investment Group first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 16 quarters since.
  • Stonegate Investment Group's Thermo Fisher Scientific position peaked at $4.19M in Q3 2024.
  • 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.